References
- Gaddum J. H., Picarelli Z. P. Two kinds of tryptamine receptors. Br. J. Pharmacol. Chemother. 1957; 12: 323–328
- Donatsch P., Engel G., Richardson B. J., Stadler P. A. ICS 205–930: A highly selective and potent antagonist at peripheral neuronal 5-hydroxytryptamine (5HT) receptors. Br. J. Pharmacol. 1984; 81: 34P
- Fozard J. R. MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol. 1984; 326: 36–44
- Costa M., Furness J. B. The sites of action of 5HT in nerve muscle preparations from the guinea pig small intestine and colon. Br. J. Pharmacol. 1979; 65: 237–248
- Engel G., Müller-Schweinitzer E., Palacios J. M. 2-[125lodo]LSD, a new ligand for the characterisation and localisation of 5HT2-receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1984; 325: 328–336
- Engel G., Hoyer D., Berthold R., Wagner H. (±)[125lodo]cyanopindolol, a new ligand for β-adrenoceptors: Identification and quantitation of subclasses of β-adrenoceptors in guinea pig. Naunyn-Schmiedeberg's Arch. Pharmacol. 1981; 317: 277–285
- De Lean A., Hancock A. A., Lefkowitz R. J. Validation and Statistical Analysis of a Computer Modeling Method for Quantitative Analysis of Radioligand Binding Data for Mixtures of Pharmacological Receptor Subtypes. Mol. Pharmacol. 1981; 21: 5–16
- Leysen J. E., Niemegeers C. J.E., Van Nueten J. M., Laduron P. M. [3H]Ketanserin (R 41 468), a selective H-ligand for serotonin2-receptor binding sites. Mol. Pharmacol. 1982; 21: 301–314